Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results

• Josep‐Maria Ribera,
• Mireia Morgades,
• Jordi Ribera,
• Pau Montesinos,
• Isabel Cano‐Ferri,
• Pilar Martínez,
• Jordi Esteve,
• Daniel Esteban,
• María García‐Fortes,
• Natalia Alonso,
• José González‐Campos,
• Arancha Bermúdez,
• Anna Torrent,
• Eulàlia Genescà,
• Clara Maluquer,
• Joaquín Martínez‐López,
• Ramón García‐Sanz

Affiliations

Josep‐Maria Ribera

Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain

Mireia Morgades

Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain

Jordi Ribera

Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain

Pau Montesinos

Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain

Isabel Cano‐Ferri

Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain

Pilar Martínez

Department of Hematology Hospital Doce de Octubre Madrid Spain

Jordi Esteve

Department of Hematology Hospital Clínic Barcelona Spain

Daniel Esteban

Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain

María García‐Fortes

Department of Hematology Hospital Universitario Virgen de la Victoria Málaga Spain

Natalia Alonso

Department of Hematology Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain

José González‐Campos

Department of Hematology Hospital Universitario Virgen del Rocío. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/CIBERONC. Universidad de Sevilla Sevilla Spain

Arancha Bermúdez

Department of Hematology Hospital Universitario Marqués de Valdecilla Santander Spain

Anna Torrent

Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain

Eulàlia Genescà

Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain

Clara Maluquer

Department of Hematology, ICO‐Hospital Duran i Reynals Hospitalet de Llobregat Spain

Joaquín Martínez‐López

Department of Hematology Hospital Doce de Octubre Madrid Spain

Ramón García‐Sanz

Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL) CIBERONC and Center for Cancer Research‐IBMCC (USAL‐CSIC) Salamanca Spain